RecruitingNot applicableNCT07151755

Microneedle Intra-Arterial Injection for Retinal Artery Occlusion

Studying Central retinal artery occlusion

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Intervention: Vitrectomy + Direct Intra-Arterial Microneedle Thrombolysis + Standard Care(procedure)
Enrollment: 24 enrolled
Eligibility: 18 years · All sexes
Timeline: 2025 – 2027

Study locations (1)

Eye Center of the Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07151755 on ClinicalTrials.gov

Other trials for Central retinal artery occlusion

Additional recruiting or active studies for the same condition.

See all trials for Central retinal artery occlusion →

← Back to all trials